Lunch & Learn
De-Risking Strategies and Tools to Accelerate the Path to IND
Advancing your drug or vaccine candidate from late-stage discovery into the clinic is one of the most critical steps in development. Join our expert in this lunch and learn to more about lead selection and protein optimization services to help identify and mitigate manufacturing and immunosafety risks.
Date:
Thursday, February 13th, 2025
Time:
12:00pm–1:00pm
Location:
BioLabs NYC
6th Floor Café
180 Varick St
New York, NY 10014
Meet Our Expert
Yvette Stallwood, Ph.D.
Senior Director, Head of Early Development Services
Yvette Stallwood completed her Ph.D. at the University of Birmingham (UK) and has a background in Virology, Cell & Molecular Biology. She joined Lonza in 2007 and is Head of Early Development Services. The Early Development Services teams are focused on the development and provision of services to support the development and de-risking of new biotherapeutic proteins and vaccines with a focus on immunosafety, manufacturability, antibody humanization and protein expression.
Complete the form to register!
